4//SEC Filing
ORiordan Anne 4
Accession 0001765581-19-000031
CIK 0001232524other
Filed
Mar 3, 7:00 PM ET
Accepted
Mar 4, 7:51 PM ET
Size
7.5 KB
Accession
0001765581-19-000031
Insider Transaction Report
Form 4
ORiordan Anne
Director
Transactions
- Award
Ordinary Shares
2019-02-28+2,840→ 2,840 total - Award
Non-Qualified Stock Option (right to buy)
2019-02-28+7,100→ 7,100 totalExercise: $140.03Exp: 2029-02-27→ Ordinary Shares (7,100 underlying)
Footnotes (2)
- [F1]These restricted stock units are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Each restricted stock unit represents a contingent right to receive one ordinary share upon the vesting of the unit. Subject to the Reporting Person's continuous service and certain additional conditions, these units will vest in equal annual installments over three years measured from the vesting commencement date of February 14, 2019, with 1/3 vesting on the first anniversary of the vesting commencement date and the remainder vesting in equal annual installments over the subsequent two years.
- [F2]These options are granted pursuant to the Issuer's 2007 Non-Employee Directors Stock Award Plan. Subject to the Reporting Person's continuous service and certain additional conditions, these options will vest 1/3 on February 14, 2020 and in 24 equal monthly installments thereafter.
Documents
Issuer
Jazz Pharmaceuticals plc
CIK 0001232524
Entity typeother
Related Parties
1- filerCIK 0001767870
Filing Metadata
- Form type
- 4
- Filed
- Mar 3, 7:00 PM ET
- Accepted
- Mar 4, 7:51 PM ET
- Size
- 7.5 KB